Skip to main content
Clinical Trials/CTRI/2015/01/005397
CTRI/2015/01/005397
Recruiting
Phase 3

A randomized double blind controlled clinical trial of an Ayurvedic formulation for the prevention and management of coronary heart disease.

Department of Science Technology0 sites1,000 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Science Technology
Enrollment
1000
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Science Technology

Eligibility Criteria

Inclusion Criteria

  • Diagnosed cases of CHD consenting to participate in clinical drug trial program were included in the study.
  • These CHD patient showing dyslipidemia, atherosclerotic, ischemic changes, elevated homocysteine and inflammatory markers, concentration with certain psychological complaints mainly sleep disturbances were treated with test formulation.
  • The diagnosis of CHD patients were done on the basis of clinical as well as laboratory findings.

Exclusion Criteria

  • Patients suffering from chronic illness like T.B., Rheumatoid arthritis, diagnosed IHD cases; Type\-1 diabetic patients; Evidence of hypo or hyperthyroidism; Age above 75 years.

Outcomes

Primary Outcomes

Not specified

Similar Trials